1. What Is the Phage Engineering Market?
The Phage Engineering Market covers genetic engineering of bacteriophages to create therapeutics with modified host range, enhanced antibacterial specificity, and novel delivery for antimicrobial therapy, drug delivery, and synthetic biology. Phage engineering encompasses engineered anti-biofilm phages, phage-antibiotic combination combinations, phage cocktail design, and phage-based drug delivery systems. Market dynamics reflect antimicrobial resistance driving investment in phage therapy alternatives, engineered phage specificity improvement addressing narrow wild-type host range, and FDA and EMA regulatory pathway development.
2. Phage Engineering Market Size & Forecast
3. Emerging Technologies
- Phage library genomics databases cataloguing tens of thousands of bacterial phage sequences for target-matched therapy selection are advancing as personalised phage therapy tools. Growing adoption at phage therapy centres is driven by patient-matched phage selection requirements.
- Directed phage evolution platforms using AI-guided mutagenesis to improve phage binding to antibiotic-resistant bacteria are advancing. Growing adoption at phage engineering companies is driven by host range expansion requirements.
- Phage-antibiotic combination benefit screening platforms identifying phage-antibiotic combinations with enhanced antibacterial killing are advancing. Growing adoption at phage therapy developers is driven by combination therapy efficacy improvement requirements.
- Endolysin-armed phage engineering adding additional bacterial cell wall lytic enzyme to phage particle are advancing as potency improvement tools. Growing adoption is driven by phage killing speed and efficacy requirements.
Comparable technologies are influencing adjacent market segments in similar ways. Read more in our Precision Fermentation Platform Market.
4. Key Market Opportunity
The highest-value opportunity in the Phage Engineering Market is the personalised phage therapy for multi-drug resistant infection opportunity, where compassionate use success stories drive clinical investment in engineered phage as AMR solution. Engineered anti-biofilm phage creates a high-value clinical opportunity as prosthetic joint and cardiac device biofilm infections represent high unmet medical need. CRISPR-phage precision antibacterial therapy creates a pipeline investment opportunity as microbiome-preserving selective killing demonstrates clinical differentiation. Asia Pacific phage engineering creates geographic expansion as Chinese and South Korean phage engineering research investment and AMR clinical programme development grows.
5. Top Companies in the Phage Engineering Market
The following organisations hold leading positions in the Phage Engineering Market. The full report provides revenue share, SWOT analysis, and competitive benchmarking for each player.
- Adaptive Phage Therapeutics
- BiOptio Diagnostics
- Pherecydes Pharma
- Locus Biosciences
- iNtRON Biotechnology
- Armata Pharmaceuticals
- Enbiotix
- Synthetic Biologics
- UC San Diego CIPA
- Micreos
6. Market Segmentation
The Phage Engineering Market is analysed across 4 segmentation dimensions. Revenue data, growth rates, and competitive intensity by sub-segment are available in the full report.
| Segmentation | Sub-Segments |
|---|---|
| By Application | Phage Therapy AMR Drug Delivery Phage Cocktail Anti-Biofilm Synthetic Biology |
| By Modification | Tail Fibre Engineering Endolysin Fusion CRISPR-Engineered Tail Spike |
| By Indication | MRSA P. aeruginosa A. baumannii Biofilm Infection |
| By Geography | North America Europe Asia Pacific Latin America Middle East and Africa |
7. Key Market Trends (2026–2034)
Three major forces are shaping the Phage Engineering Market trajectory over the forecast period:
Phage Therapy Compassionate Use Cases Demonstrate Clinical Success in Multi-Drug Resistant Infections.UC San Diego Centre for Innovative Phage Applications achieving 60-plus compassionate use cases in 2024 with 75 percent clinical improvement demonstrates phage therapy proof in drug-resistant infections. A. baumannii systemic infection and S. aureus endocarditis phage therapy compassionate cases demonstrate life-saving clinical outcomes in infections with no effective antibiotic alternatives.
Adaptive Phage Therapeutics and BiOptio Achieve Phage Therapy IND Approval and Phase 1 Clinical Entry.Adaptive Phage Therapeutics achieving IND approval for engineered phage therapy for bone and joint prosthetic infection in 2024 demonstrates engineered phage therapeutic regulatory pathway entry. BiOptio Phase 1 trial for phage therapy in UTI demonstrating safety in first-in-human engineered phage therapeutic demonstrates human phage safety profile.
CRISPR-Engineered Phages Enable Selective Targeting of Specific Bacterial Strains Without Microbiome Disruption.CRISPR-engineered phage research demonstrating selective killing of target bacteria without disrupting surrounding microbiome members in 2024 demonstrates the precision advantage of engineered phage over broad-spectrum antibiotics. CRISPR-phage killing of C. difficile without disrupting commensal bacteria demonstrates clinically meaningful microbiome-preserving antibacterial specificity.
For related market intelligence, see the Phage Display Market.
8. Segmental Analysis
By application, the Phage Therapy AMR segment dominated the Phage Engineering Market in 2025. Representing the largest clinical investment category as compassionate use and Phase 1 trials create proof-of-concept revenue. The CRISPR-Engineered Precision Phage segment is the fastest-growing category, advancing as CRISPR-phage microbiome-preserving killing demonstrates clinically meaningful differentiation over wild-type phage.
By indication, the MRSA and A. baumannii segment dominated in 2025 as the highest clinical unmet need AMR indications.
By modification type, the Tail Fibre Engineering segment dominated the Phage Engineering Market in 2025, as tail fibre protein modification for expanded host range and targeted bacterial killing represents the most established phage engineering approach. CRISPR-Engineered phages are the fastest-growing modification category, driven by precision genome editing enabling programmable phage therapeutic design for specific antimicrobial resistance applications.
9. Regional Analysis
Regional demand patterns across the Phage Engineering Market reflect differences in regulation, technological maturity, and capital investment.
Largest Market Share
North America accounted for the largest share of the Phage Engineering Market in 2025, holding 44.6% of the global market. Biotechnology companies, academic research institutions, and phage therapy clinical programmes are advancing engineered bacteriophage development for antimicrobial resistance treatment, precision microbiome modulation, and diagnostic applications. FDA regulatory engagement with phage therapy compassionate use and growing clinical research interest in phage engineering as an antimicrobial resistance countermeasure are encouraging development. Strong biotechnology research investment, established academic phage biology research programmes, and growing antimicrobial resistance treatment urgency are generating regional phage engineering development activity.
Highest CAGR Region
Europe is expected to register the highest CAGR of 23.86% during the forecast period. European phage therapy clinical programmes, academic microbiology institutions, and biotechnology companies across Belgium, Georgia, France, Germany, and Poland are advancing phage engineering for antimicrobial resistance treatment and precision microbiome applications. European Medicines Agency engagement with phage therapy regulatory pathways and growing academic research investment in phage engineering are encouraging clinical and commercial development. Rising antimicrobial resistance urgency in European healthcare and growing demand for novel treatment approaches are generating European phage engineering adoption.
10. Full Report with Exclusive Insights
The complete published market report includes an in-depth analysis of market dynamics, industry trends, competitive landscape, regional outlook, and future growth opportunities. The study provides detailed market sizing and forecasts across key segments and geographies, along with comprehensive insights into drivers, restraints, opportunities, challenges, technological advancements, regulatory landscape, and evolving consumer and industry trends. The report also features company profiles, strategic developments, market share analysis, and actionable recommendations to support informed business decision-making. Additionally, the syndicated report package typically includes forecast datasets, charts and figures, research methodology, and analyst support for strategic interpretation and planning.
Advanced Strategic & Custom Intelligence
In addition to the standard syndicated report package, TrendX Insights can provide the following advanced strategic analyses and customized intelligence solutions for any market:
Standard Report Coverage
- • Competitor Analysis
- • Country Trade Analysis
- • Import & Export Analysis
- • Porter’s Five Forces Analysis
- • SWOT Analysis by Companies
- • TrendX Insights Quadrant Positioning
- • Pricing Analysis
- • Detailed Macro-Economic Indicators Assessment
- • List of Raw Material Suppliers
- • Regulatory Framework Assessment
- • Supply Chain Resilience Mapping
- • Value Chain Analysis
- • Technology Adoption Trends and Innovation Tracking
- • Custom Company Profiling and Benchmarking
Exclusive Sections With Additional Cost
- • Agentic AI Readiness Score
- • TAM, SAM, and SOM Analysis
- • AI Act & Privacy Compliance Audit
- • Channel Partner Ecosystem Mapping
- • China + 1 Strategy Analysis
- • Circular Economy Opportunities Assessment
- • Competitor Benchmarking KPI Analysis
- • Country-Level Opportunity Mapping
- • Digital Maturity Matrix
- • Ecosystem Interdependency Mapping
- • ESG & Decarbonization Roadmap
- • Geopolitical Friction Scorecard
- • Geopolitical Risk Assessment
- • Humanoid Workforce Impact Analysis
- • Investment Heatmap
- • List of Distributors and Channel Partners
- • Market Entry Strategy Assessment
- • Mergers & Acquisitions (M&A) Analysis
- • Patent & Intellectual Property (IP) Analysis
- • Pilot Project Analysis
- • Potential High-Growth Region/Country Investment Assessment
- • Product Comparison Analysis
- • Product Revenue Analysis
- • R&D Investment Analysis in Emerging Technologies
- • Raw Material Scarcity Forecast
Note: For highly customized requirements, deeper strategic assessments, company-specific intelligence, or tailored consulting support, please contact TrendX Insights.
Full Report with Exclusive Insights
Available to clients on request
Explore Our Published Reports Library
This page covers market-level data estimates. For comprehensive published research reports including full methodology, primary data, and detailed company profiles, browse the TrendX Insights Published Reports Library.
Visit Published Reports Library ›11. Related Market Reports
Frequently Asked Questions
The Phage Engineering Market was valued at USD 601.10 Mn in 2025 and is projected to reach USD 2,645.90 Mn by 2034, growing at a CAGR of 17.9% over the 2026–2034 forecast period.
The Phage Engineering Market is projected to grow at a CAGR of 17.9% from 2026 to 2034.
North America accounted for the largest share of the Phage Engineering Market in 2025, holding 44.6% of the global market.
The leading companies in the Phage Engineering Market include Adaptive Phage Therapeutics, BiOptio Diagnostics, Pherecydes Pharma, Locus Biosciences, iNtRON Biotechnology, Armata Pharmaceuticals, Enbiotix, Synthetic Biologics, UC San Diego CIPA, Micreos.
Phage therapy compassionate use cases demonstrate clinical success in multi-drug resistant infections.
By application, the Phage Therapy AMR segment dominated the Phage Engineering Market in 2025.
How to Order
Purchasing a TrendX Insights report is straightforward. Our process is designed to be transparent and risk-free for buyers, with a 20% upfront model and full delivery before the balance payment.
This is the price of the syndicated report. Any custom inclusions beyond the Table of Contents will be scoped and priced separately. For the full list of what is covered in the syndicated report, refer to the Table of Contents tab.
A curated, condensed version of this report for students, researchers, and academic institutions. Ideal for thesis work, dissertations, and academic projects. Delivered as PDF to your institutional email.
Valid student ID or institutional email required. For educational and non-commercial use only.